search button
Open Access

P40 and TTF‑1 double‑expressing non‑small cell lung cancer with EML4‑ALK and PIK3CA gene mutations: A case report and review of the literature

  • Authors:
    • Ying Cai
    • Hongsheng Liu
    • Xiaodan Chen
    • Junjie Yang
    • Bin Huang

  • View Affiliations

  • Published online on: December 20, 2022     https://doi.org/10.3892/ol.2022.13645
  • Article Number: 59

  • Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

P40 and thyroid transcription factor‑1 (TTF‑1) dual expression in non‑small cell lung cancer (NSCLC) is a rare occurrence. However, the presence of EML4‑ALK and PIK3CA gene mutations in this type of cancer is unknown. The present study describes the case of a 38‑year‑old male patient who had never smoked. A 4.5‑cm mass adjacent to his right upper mediastinum was detected by a computed tomography (CT) scan of the chest. Biopsy of the level four lymph nodes in the right mediastinum revealed microscopic morphological features typical of high‑grade NSCLC. Immunohistochemical findings resembled those reported previously for several cases of NSCLC with the dual expression of P40 and TTF‑1 markers. In addition, echinoderm microtubule‑associated protein‑like 4‑anaplastic lymphoma kinase (EML4‑ALK) and phosphatidylinositol‑4,5‑bisphosphate 3‑kinase catalytic subunit a (PIK3CA) gene mutations were detected using high‑throughput next‑generation sequencing. To the best of our knowledge, this is the first report of NSCLC with the expression of P40 and TTF‑1 as well as EML4‑ALK and PIK3CA gene mutations. The presence of this type of tumor should be considered in patients with NSCLC who have never smoked and may have unique clinicopathological features.
View Figures
View References

Related Articles

Journal Cover

February-2023
Volume 25 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Cai Y, Liu H, Chen X, Yang J and Huang B: P40 and TTF‑1 double‑expressing non‑small cell lung cancer with EML4‑ALK and PIK3CA gene mutations: A case report and review of the literature. Oncol Lett 25: 59, 2023.
APA
Cai, Y., Liu, H., Chen, X., Yang, J., & Huang, B. (2023). P40 and TTF‑1 double‑expressing non‑small cell lung cancer with EML4‑ALK and PIK3CA gene mutations: A case report and review of the literature. Oncology Letters, 25, 59. https://doi.org/10.3892/ol.2022.13645
MLA
Cai, Y., Liu, H., Chen, X., Yang, J., Huang, B."P40 and TTF‑1 double‑expressing non‑small cell lung cancer with EML4‑ALK and PIK3CA gene mutations: A case report and review of the literature". Oncology Letters 25.2 (2023): 59.
Chicago
Cai, Y., Liu, H., Chen, X., Yang, J., Huang, B."P40 and TTF‑1 double‑expressing non‑small cell lung cancer with EML4‑ALK and PIK3CA gene mutations: A case report and review of the literature". Oncology Letters 25, no. 2 (2023): 59. https://doi.org/10.3892/ol.2022.13645